Non-Hodgkin Lymphoma

Filter By:
06:46
At the iwNHL 2014, Prof Francesco D'Amore (Aarhus University, Aarhus, Denmark) interviews Dr Elaine Jaffe (National Cancer Institute, Maryland, USA) and Prof Laurence de Leval (IUP Institut universitaire de pathologie, Lausanne, Switzerland) about their involvement at this workshop. Dr Jaffe describes the important abnormal contribution of B-cell p...
by:EMJ | 37 views
07:59
At the iwNHL 2014, Dr Rafael Fonseca (Mayo Clinic, Arizona, USA) interviews Prof Keith Stewart (Mayo Clinic, Arizona, USA) and Prof Leif Bergsagel (Mayo Clinic, Arizona, USA), all doctors with an interest in myeloma, about the application of myeloma biology and therapies in lymphoma. Prof Stewart describes tumour heterogeneity and suggests a parall...
by:EMJ | 88 views
10:46
At the iwNHL 2014, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Wolfram Brugger (University of Freiburg, Villingen-Schwe​nningen, Germany) and Dr Myron Czuczman (Roswell Park Cancer Institute, New York, USA) about the current and future clinical application of targeted or ch...
by:EMJ | 67 views
07:00
At the iwNHL 2014, Dr Steven Rosen (City of Hope National Medical Center, California, USA) describes the progress made in understanding the biology and management of non-Hodgkin lymphoma. Now, there is need to consider new drug combinations to maximise efficacy. Alternatives to chemotherapy includin...
by:EMJ | 64 views
07:46
At the iwNHL 2014, Dr Mathias Rummel (Justus-Liebig University-Hosp​ital, Gie├čen, Germany) describes his research investigating the use of bendamustine plus rituximab in treating indolent and mantle-cell lymphomas, highlighting the clinical implications of his long-term findings. He also presents an ...
by:EMJ | 66 views
07:22
At the iwNHL 2014, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Randy Gascoyne (British Columbia Cancer Agency, Vancouver, Canada) about the significance of the lymphoma microenvironmen​t in tumour biology and therapy. Understanding the biology of the lymphoma microenvironme...
by:EMJ | 66 views
02:14
At the iwNHL 2014, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Randy Gascoyne (British Columbia Cancer Agency, Vancouver, Canada) about the significance of the lymphoma microenvironmen​t in tumour biology and therapy. Improved trial designs, consideration of clinical variab...
by:EMJ | 75 views
05:53
At the iwNHL 2014, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Randy Gascoyne (British Columbia Cancer Agency, Vancouver, Canada) about the significance of the lymphoma microenvironmen​t in tumour biology and therapy. The interaction between tumour cells and non-tumour cell...
by:EMJ | 74 views
12:23
Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma and it can be aggressive. Drs. John Gribben and Wyndham Wilson discuss new research shows promise for many. Get email alerts | http://www.p... Subscribe on YouTube | http://www.y... Like on Facebook | http://ww......
by:patientpower | 101 views
23:18
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA), Prof Anton Hagenbeek (Academic Medical Center, Amsterdam, Netherlands), Prof Michael Pfreundschuh (University of Saarland, Homburg-Saar, Germany) and Dr Myron...
by:EMJ | 142 views
Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)